combination therapy of cognitive rehabilitation and emotion regulation based on dialectical behavior therapy in HIV patients with associated neurocognitive disorders.

The effectiveness of combination therapy of cognitive rehabilitation and emotion regulation based on dialectical behavior therapy on cognitive functions, emotional problems and quality of life of HIV patients with associated neurocognitive disorders.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211118053093N2

Enrollment

Registered

2022-01-09

Start date

2021-12-20

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV. Human immunodeficiency virus [HIV] disease

Interventions

Intervention 1: "Intervention group 1:" Cognitive rehabilitation 12 sessions one hour, twice a week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Receiving antiretroviral therapy for at least 6 months Plasma HIV- RNA lesser or equal to 50 cells in one mililiter for at least 6 months Number of lymphocytes +T CD4 less than 350 cells in 1 microliter for at least six months Proficiency in Persian Informed consent

Exclusion criteria

Exclusion criteria: neurodegenerative diseases severe psychiatric disorder metabolic encephalopathy use of psychotropic drugs head trauma

Design outcomes

Primary

Measure	Time frame
Quality of life of HIV patients with associated neurocognitive disorders. Timepoint: Before treatment End of treatment Four months after treatment. Method of measurement: Quality of Life Questionnaire.;Cognitive Function. Timepoint: Before treatment End of treatment Four months after treatment. Method of measurement: Cognitive Function Questionnaire.;Emotional problems. Timepoint: Before treatment End of treatment Four months after treatment. Method of measurement: Emotional Problems Questionnaire.	—

Measure

Time frame

Quality of life of HIV patients with associated neurocognitive disorders. Timepoint: Before treatment End of treatment Four months after treatment. Method of measurement: Quality of Life Questionnaire.;Cognitive Function. Timepoint: Before treatment End of treatment Four months after treatment. Method of measurement: Cognitive Function Questionnaire.;Emotional problems. Timepoint: Before treatment End of treatment Four months after treatment. Method of measurement: Emotional Problems Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Razeghian Jahromi

Shiraz University of Medical Sciences

leilarazeghian1366@gmail.com+98 71 3260 5701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026